BamSEC and AlphaSense Join Forces
Learn More

CME Group Inc.

NASDAQ: CME    
Share price (12/20/24): $238.53    
Market cap (12/20/24): $86.0 billion

Indentures Filter

EX-4.2
from 8-K 31 pages CME Group Inc. and U.S. Bank Trust Company, National Association, as Trustee Tenth Supplemental Indenture Dated as of March 8, 2022 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 2.650% Notes Due 2032
12/34/56
EX-4.11
from 10-K 7 pages Description of Capital Stock
12/34/56
EX-4.11
from 10-K 7 pages Description of Capital Stock
12/34/56
EX-4.11
from 10-K 8 pages Description of Capital Stock
12/34/56
EX-4.3
from 8-K 25 pages CME Group Inc. and U.S. Bank National Association, as Trustee Ninth Supplemental Indenture Dated as of June 21, 2018 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 4.150% Notes Due 2048
12/34/56
EX-4.2
from 8-K 25 pages CME Group Inc. and U.S. Bank National Association, as Trustee Eighth Supplemental Indenture Dated as of June 21, 2018 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 3.750% Notes Due 2028
12/34/56
EX-4.10
from S-3ASR 2 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 24 pages CME Group Inc. and U.S. Bank National Association, as Trustee Seventh Supplemental Indenture Dated as of March 9, 2015 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 3.000% Notes Due 2025
12/34/56
EX-4.4
from 10-K 29 pages Amended and Restated Commercial Paper Dealer Agreement 4(a)(2) Program Between CME Group Inc., as Issuer and Goldman, Sachs & Co., as Dealer Dated as of October 20, 2014
12/34/56
EX-4.3
from 10-K 28 pages Amended and Restated Commercial Paper Dealer Agreement 4(2) Program Between CME Group Inc., as Issuer, and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as Dealer Dated as of October 20, 2014
12/34/56
EX-4.2
from 10-K 14 pages Commercial Paper Issuing and Paying Agent Agreement
12/34/56
EX-4.1
from 10-K 27 pages Amended and Restated Commercial Paper Dealer Agreement 4(a)(2) Program Between CME Group Inc., as Issuer and Barclays Capital Inc., as Dealer Dated as of October 20, 2014
12/34/56
EX-4.2
from 8-K 24 pages CME Group Inc. and U.S. Bank National Association, as Trustee Sixth Supplemental Indenture Dated as of September 9, 2013 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 5.300% Notes Due 2043
12/34/56
EX-4.4
from S-3ASR 61 pages CME Group Inc. and U.S. Bank National Association Indenture Dated as of [ ] Subordinated Debt Securities Cross-Reference Sheet*
12/34/56
EX-4.2
from 8-K 23 pages CME Group Inc. and U.S. Bank National Association, as Trustee Fifth Supplemental Indenture Dated as of September 10, 2012 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 3.00% Notes Due 2022
12/34/56
EX-4.1
from 8-K 98 pages CME Group Index Services LLC, Issuer CME Group Inc., Guarantor and U.S. Bank National Association, Trustee Indenture Dated as of March 18, 2010 4.40% Senior Notes Due 2018 Cross-Reference Sheet*
12/34/56
EX-4.2
from 8-K 22 pages CME Group Inc. and U.S. Bank National Association, as Trustee Fourth Supplemental Indenture Dated as of February 9, 2009 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 5.75% Notes Due 2014
12/34/56
EX-4.2
from S-8 POS 21 pages Fifth Amended and Restated Bylaws of CME Group Inc
12/34/56
EX-4.1
from S-8 POS 19 pages Third Amended and Restated Certificate of Incorporation of CME Group Inc
12/34/56
EX-4.4
from 8-K 23 pages CME Group Inc. and U.S. Bank National Association, as Trustee Third Supplemental Indenture Dated as of August 12, 2008 to Senior Debt Indenture Dated as of August 12, 2008 Establishing a Series of Securities Designated 5.40% Notes Due 2013
12/34/56